JP2009513691A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009513691A5 JP2009513691A5 JP2008538393A JP2008538393A JP2009513691A5 JP 2009513691 A5 JP2009513691 A5 JP 2009513691A5 JP 2008538393 A JP2008538393 A JP 2008538393A JP 2008538393 A JP2008538393 A JP 2008538393A JP 2009513691 A5 JP2009513691 A5 JP 2009513691A5
- Authority
- JP
- Japan
- Prior art keywords
- lipoxygenase
- medicament
- teeth
- writing
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000003820 Lipoxygenases Human genes 0.000 claims 1
- 108090000128 Lipoxygenases Proteins 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- -1 Bromotripyrrolidinophosphonium hexafluorophosphate Chemical compound 0.000 description 1
- 239000012317 TBTU Substances 0.000 description 1
- CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73148105P | 2005-10-31 | 2005-10-31 | |
| PCT/GB2006/004010 WO2007051982A1 (en) | 2005-10-31 | 2006-10-27 | Triazole compounds as lipoxygenase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009513691A JP2009513691A (ja) | 2009-04-02 |
| JP2009513691A5 true JP2009513691A5 (https=) | 2009-12-17 |
Family
ID=35810092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008538393A Withdrawn JP2009513691A (ja) | 2005-10-31 | 2006-10-27 | リポキシゲナーゼ阻害剤としてのトリアゾール化合物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20090186918A1 (https=) |
| EP (1) | EP1943234A1 (https=) |
| JP (1) | JP2009513691A (https=) |
| KR (1) | KR20080067364A (https=) |
| CN (1) | CN101300236A (https=) |
| AU (1) | AU2006310367A1 (https=) |
| BR (1) | BRPI0618079A2 (https=) |
| CA (1) | CA2627516A1 (https=) |
| EA (1) | EA200801108A1 (https=) |
| IL (1) | IL191061A0 (https=) |
| NO (1) | NO20081888L (https=) |
| NZ (1) | NZ567605A (https=) |
| WO (1) | WO2007051982A1 (https=) |
| ZA (1) | ZA200803636B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200800911A (en) * | 2005-10-20 | 2008-01-01 | Biolipox Ab | Pyrazoles useful in the treatment of inflammation |
| TW200732320A (en) * | 2005-10-31 | 2007-09-01 | Biolipox Ab | Pyrazoles useful in the treatment of inflammation |
| WO2007052000A1 (en) * | 2005-11-01 | 2007-05-10 | Biolipox Ab | Pyrazoles useful in the treatment of inflammation |
| GEP20125379B (en) | 2007-05-03 | 2012-01-10 | Pfizer Ltd | 2 -pyridine carboxamide derivatives as sodium channel modulators |
| WO2011028651A1 (en) * | 2009-09-01 | 2011-03-10 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Inhibitors of human 15-lipoxygenase-1 |
| KR101810975B1 (ko) | 2010-07-08 | 2017-12-20 | 에스케이바이오팜 주식회사 | 카바모일옥시 아릴알칸노일 아릴피페라진계 화합물을 포함하는 약학적 조성물 |
| WO2012034960A1 (en) * | 2010-09-13 | 2012-03-22 | Basf Se | Pyridine compounds for controlling invertebrate pests ii |
| EP2635565A1 (en) | 2010-11-04 | 2013-09-11 | Amgen Inc. | 5 -cyano-4, 6 -diaminopyrimidine or 6 -aminopurine derivatives as pi3k- delta inhibitors |
| JP2016501203A (ja) | 2012-11-20 | 2016-01-18 | バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ | インドールアミン２，３−ジオキシゲナーゼの阻害剤として有用な化合物 |
| KR101652577B1 (ko) * | 2013-04-19 | 2016-08-30 | 영남대학교 산학협력단 | 아미도피리딘올 유도체 또는 이의 약제학적 허용가능한 염 및 이를 유효성분으로 함유하는 혈관신생으로 인한 질환의 예방 또는 치료용 약학조성물 |
| US9403833B2 (en) * | 2014-05-14 | 2016-08-02 | Novartis Ag | Carboxamide derivatives |
| EP3108883A1 (en) * | 2015-06-22 | 2016-12-28 | Fundació Institut de Recerca Biomèdica de Bellvitge | Therapeutic uses of non-peptide inhibitors of the calcineurin - nfat signalling pathway |
| CN111057058B (zh) * | 2020-01-03 | 2021-02-02 | 浙江工业大学 | 一种制备1H-[1,2,3]-三唑并[4,5-c]喹啉类化合物的方法 |
| CN113466395B (zh) * | 2021-08-03 | 2023-11-21 | 杭州微源检测技术有限公司 | 一种检测瑞戈非尼和中间体药物中4-氯-3-三氟甲基异氰酸苯酯含量的方法 |
| CN116082253B (zh) * | 2023-02-25 | 2025-04-25 | 浙大城市学院 | 一种1-n-取代的1,2,3-三唑-4-甲酰胺衍生物及其制备方法 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1306260C (en) * | 1985-10-18 | 1992-08-11 | Shionogi & Co., Ltd. | Condensed imidazopyridine derivatives |
| US5464860A (en) * | 1988-11-30 | 1995-11-07 | Novapharme | N(pyrazol-3-yl) benzamides and pharmaceutical compositions |
| FR2639636B1 (fr) * | 1988-11-30 | 1994-03-04 | Novapharme | Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant |
| US5258397A (en) * | 1988-11-30 | 1993-11-02 | Novapharme | 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions |
| CA2135173A1 (en) * | 1992-05-20 | 1993-11-25 | Bruce E. Witzel | Ester derivatives of 4-aza-steroids |
| EP0641204B1 (en) * | 1992-05-20 | 2000-08-16 | Merck & Co. Inc. | 17-ethers and thioethers of 4-aza-steroids |
| US6372770B1 (en) * | 1994-10-12 | 2002-04-16 | Euro-Celtique, S.A. | Benzoxazoles |
| US5663357A (en) * | 1995-11-22 | 1997-09-02 | Allergan | Substituted heteroarylamides having retinoid-like biological activity |
| GB9603095D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
| ATE306481T1 (de) * | 1999-05-12 | 2005-10-15 | Ortho Mcneil Pharm Inc | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen |
| US6632815B2 (en) * | 1999-09-17 | 2003-10-14 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
| US7393842B2 (en) * | 2001-08-31 | 2008-07-01 | University Of Connecticut | Pyrazole analogs acting on cannabinoid receptors |
| GB0002666D0 (en) * | 2000-02-04 | 2000-03-29 | Univ London | Blockade of voltage dependent sodium channels |
| WO2001058869A2 (en) * | 2000-02-11 | 2001-08-16 | Bristol-Myers Squibb Company | Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| GB0011094D0 (en) * | 2000-05-08 | 2000-06-28 | Black James Foundation | Gastrin and cholecystokinin receptor ligands (III) |
| WO2002024656A1 (en) * | 2000-09-22 | 2002-03-28 | Nihon Nohyaku Co., Ltd. | N-(4-pyrazolyl)amide derivatives, chemicals for agricultural and horticultural use, and usage of the same |
| JP4465133B2 (ja) * | 2001-02-08 | 2010-05-19 | クミアイ化学工業株式会社 | イソオキサゾリン誘導体及びこれを有効成分とする除草剤 |
| DE10110750A1 (de) * | 2001-03-07 | 2002-09-12 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
| AU2002363250A1 (en) * | 2001-11-01 | 2003-05-12 | Icagen, Inc. | Pyrazole-amides and-sulfonamides |
| TWI263497B (en) * | 2002-03-29 | 2006-10-11 | Lilly Co Eli | Pyridinoylpiperidines as 5-HT1F agonists |
| WO2004039795A2 (en) * | 2002-10-29 | 2004-05-13 | Fujisawa Pharmaceutical Co., Ltd. | Amide compounds for the treatment of hyperlipidemia |
| JP2006512314A (ja) * | 2002-11-01 | 2006-04-13 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ｊａｋインヒビターおよび他のプロテインキナーゼインヒビターとしての組成物の使用 |
| EP1571671A4 (en) * | 2002-12-13 | 2008-04-02 | Matsushita Electric Industrial Co Ltd | OPTICAL DATA DISTRIBUTION EQUIPMENT |
| US7429581B2 (en) * | 2002-12-23 | 2008-09-30 | Sanofi-Aventis Deutschland Gmbh | Pyrazole-derivatives as factor Xa inhibitors |
| EP1603897A1 (en) * | 2003-03-14 | 2005-12-14 | Biolipox AB | Pyrazole compounds useful in the treatment of inflammation |
| SE0300705D0 (sv) * | 2003-03-14 | 2003-03-14 | Biolipox Ab | New compounds |
| US7429603B2 (en) * | 2003-04-25 | 2008-09-30 | 3-Dimensional Pharmaceuticals, Inc. | C-fms kinase inhibitors |
| GB0312609D0 (en) * | 2003-06-02 | 2003-07-09 | Astrazeneca Ab | Novel compounds |
| WO2006032852A1 (en) * | 2004-09-20 | 2006-03-30 | Biolipox Ab | Pyrazole compounds useful uin the treatment of inflammation |
| TW200800911A (en) * | 2005-10-20 | 2008-01-01 | Biolipox Ab | Pyrazoles useful in the treatment of inflammation |
| TW200732320A (en) * | 2005-10-31 | 2007-09-01 | Biolipox Ab | Pyrazoles useful in the treatment of inflammation |
| WO2007052000A1 (en) * | 2005-11-01 | 2007-05-10 | Biolipox Ab | Pyrazoles useful in the treatment of inflammation |
-
2006
- 2006-10-27 ZA ZA200803636A patent/ZA200803636B/xx unknown
- 2006-10-27 CN CNA2006800405285A patent/CN101300236A/zh active Pending
- 2006-10-27 JP JP2008538393A patent/JP2009513691A/ja not_active Withdrawn
- 2006-10-27 EP EP06808363A patent/EP1943234A1/en not_active Withdrawn
- 2006-10-27 WO PCT/GB2006/004010 patent/WO2007051982A1/en not_active Ceased
- 2006-10-27 AU AU2006310367A patent/AU2006310367A1/en not_active Abandoned
- 2006-10-27 BR BRPI0618079-5A patent/BRPI0618079A2/pt not_active IP Right Cessation
- 2006-10-27 US US12/084,400 patent/US20090186918A1/en not_active Abandoned
- 2006-10-27 EA EA200801108A patent/EA200801108A1/ru unknown
- 2006-10-27 KR KR1020087013018A patent/KR20080067364A/ko not_active Withdrawn
- 2006-10-27 NZ NZ567605A patent/NZ567605A/en unknown
- 2006-10-27 CA CA002627516A patent/CA2627516A1/en not_active Abandoned
-
2008
- 2008-04-21 NO NO20081888A patent/NO20081888L/no not_active Application Discontinuation
- 2008-04-27 IL IL191061A patent/IL191061A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009513691A5 (https=) | ||
| ATE515505T1 (de) | Heterocyclische fxr-bindende verbindungen | |
| JP2011518833A5 (https=) | ||
| TNSN07431A1 (en) | Imidazoquinolines as lipid kinase inhibitors | |
| JP2010502730A5 (https=) | ||
| JP2011529054A5 (https=) | ||
| ATE555105T1 (de) | Heterocyclische fxr-bindende verbindungen | |
| JP2009543795A5 (https=) | ||
| MX2008010931A (es) | Quinolonas utiles como inhibidores de sintasa de oxido nitrico inducibles. | |
| TW200833663A (en) | Therapeutic agents | |
| CA2565660A1 (en) | Ortho substituted aryl or heteroaryl amide compounds | |
| JP2012522847A5 (https=) | ||
| JP2010535870A5 (https=) | ||
| JP2010504286A5 (https=) | ||
| MX2009012125A (es) | Compuestos terapeuticos. | |
| GB2454615A (en) | Antidiabetic azabicyclo (3.1.0) hexan compounds | |
| RU2011113967A (ru) | Новое производное простагландина i2 | |
| RU2481345C2 (ru) | Замещенные (оксазолидинон-5-ил-метил)-2-тиофен-карбоксамиды и их применение в области свертывания крови | |
| JP2012507535A5 (https=) | ||
| WO2014017093A1 (ja) | ベンゼン環縮合含窒素５員複素環式化合物、またはその薬理学的に許容される塩 | |
| JP2015508092A5 (https=) | ||
| CA2796933A1 (en) | 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives for the therapy of transthyretin amyloidosis | |
| JP2010506919A5 (https=) | ||
| JP2010534246A5 (https=) | ||
| RU2012150799A (ru) | Композиция для борьбы с заболеваниями растений и ее применение |